Trials / Recruiting
RecruitingNCT05379101
Intracardiac Flow Assessment in Cardiac Amyloidosis
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- Mayo Clinic · Academic / Other
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Accepted
Summary
The primary objective of this study is to define the intracardiac flow imaging biomarkers in cardiac amyloidosis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Cardiac magnetic resonance image (CMR) | A magnetic resonance imaging study for assessment of cardiac structure and intracardiac flow |
| DIAGNOSTIC_TEST | Transthoracic Echocardiogram (TTE) | An imaging test that uses soundwaves that cannot be heard (ultrasound) to take pictures of the heart and vessels. |
| DIAGNOSTIC_TEST | Six-minute Walk Test | A self-paced, test of exercise capacity performed unencouraged intensity that measures the distance that patients can walk on a flat, hard surface in a period of 6 minutes |
Timeline
- Start date
- 2022-07-20
- Primary completion
- 2026-05-01
- Completion
- 2026-06-01
- First posted
- 2022-05-18
- Last updated
- 2025-07-14
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05379101. Inclusion in this directory is not an endorsement.